{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:05:02Z","timestamp":1781701502994,"version":"3.54.5"},"reference-count":36,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Center","doi-asserted-by":"publisher","award":["2017\/26\/D\/NZ6\/00136"],"award-info":[{"award-number":["2017\/26\/D\/NZ6\/00136"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>\u03b2-Lactam antibiotics are most commonly used in the critically ill, but their effective dosing is challenging and may result in sub-therapeutic concentrations that can lead to therapy failure and even promote antimicrobial resistance. In this study, we present the analytical tool enabling specific and sensitive determination of the sole biologically active fraction of piperacillin and imipenem in biological material from the critically ill. Thin-film microextraction sampling technique, followed by rapid liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) analysis, was optimized and validated for the quantitative determination of antibiotics in blood and bronchoalveolar lavage (BAL) specimens collected from intensive care unit (ICU) patients suffering from ventilation-associated pneumonia (n = 18 and n = 9, respectively). The method was optimized and proved to meet the criteria of US Food and Drug Administration (FDA) guidelines for bioanalytical method validation. Highly selective, sensitive, accurate and precise analysis by means of thin-film microextraction\u2013LC-MS\/MS, which is not affected by matrix-related factors, was successfully applied in clinical settings, revealing poor penetration of piperacillin and imipenem from blood into BAL fluid (reflecting the site of bacterial infection), nonlinearity in antibiotic binding to plasma-proteins and drug-specific dependence on creatinine clearance. This work demonstrates that only a small fraction of biologically active antibiotics reach the site of infection, providing clinicians with a high-throughput analytical tool for future studies on personalized therapeutic drug monitoring when tailoring the dosing strategy to an individual patient.<\/jats:p>","DOI":"10.3390\/molecules27030926","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:12:56Z","timestamp":1643501576000},"page":"926","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Quantitative Determination of Unbound Piperacillin and Imipenem in Biological Material from Critically Ill Using Thin-Film Microextraction-Liquid Chromatography-Mass Spectrometry"],"prefix":"10.3390","volume":"27","author":[{"given":"Robert","family":"W\u0142odarski","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, 10th Military Research Hospital and Polyclinic, 85-681 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-4708","authenticated-orcid":false,"given":"Karolina","family":"\u017buchowska","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics and Molecular Pharmacology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-0816","authenticated-orcid":false,"given":"Wojciech","family":"Filipiak","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics and Molecular Pharmacology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhin.2018.08.017","article-title":"Efficacy of antibiotic prophylaxis against ventilator-associated pneumonia","volume":"101","author":"Mirtalaei","year":"2019","journal-title":"J. Hosp. Infect."},{"key":"ref_2","first-page":"742","article-title":"Microbiology of Ventilator-Associated Pneumonia","volume":"50","author":"Park","year":"2005","journal-title":"Respir. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3855\/jidc.634","article-title":"Ventilator-associated pneumonia in a tertiary care hospital in India: Role of multi-drug resistant pathogens","volume":"4","author":"Joseph","year":"2010","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_4","first-page":"248","article-title":"Cost analysis of ventilator-associated pneumonia in Turkish medical-surgical intensive care units","volume":"4","author":"Karaoglan","year":"2010","journal-title":"Infez. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/CCM.0b013e318180fe62","article-title":"Antibiotic resistance\u2014What\u2019s dosing got to do with it?","volume":"36","author":"Roberts","year":"2008","journal-title":"Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425255.2010.506187","article-title":"Pharmacokinetic evaluation of piperacillin-tazobactam","volume":"6","author":"Hayashi","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2014.131","article-title":"Pulmonary penetration of piperacillin and tazobactam in critically ill patients","volume":"96","author":"Felton","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mcp.2002.122526","article-title":"Tissue distribution of imipenem in critically ill patients","volume":"71","author":"Tegeder","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijantimicag.2016.06.013","article-title":"Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients","volume":"48","author":"Zander","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101885","DOI":"10.1016\/j.pupt.2019.101885","article-title":"Low penetrance of antibiotics in the epithelial lining fluid. The role of inhaled antibiotics in patients with bronchiectasis","volume":"60","author":"Karampitsakos","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1128\/AAC.00951-13","article-title":"Protein binding of \u03b2-lactam antibiotics in critically Ill patients: Can we successfully predict unbound concentrations?","volume":"57","author":"Wong","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/AAC.01083-12","article-title":"Case-control study of drug monitoring of \u03b2-lactams in obese critically ill patients","volume":"57","author":"Hites","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jac\/dks053","article-title":"Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult","volume":"67","author":"Neuner","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"International Journal of Antimicrobial Agents Therapeutic drug monitoring of \u03b2-lactams in critically ill patients: Proof of concept","volume":"36","author":"Roberts","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/eri.12.162","article-title":"Treatment of carbapenem-resistant Klebsiella pneumoniae: The state of the art","volume":"11","author":"Petrosillo","year":"2014","journal-title":"Expert Rev. Anti-Infect. Therapy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cmi.2016.04.019","article-title":"The ANTIBIOPERF study: A nationwide cross-sectional survey about practices for \u03b2-lactam administration and therapeutic drug monitoring among critically ill patients in France","volume":"22","author":"Charmillon","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2008.01.037","article-title":"Simultaneous determination of five \u03b2-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection","volume":"864","author":"Denooz","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous Determination of 12 \u03b2-Lactam Antibiotics in Human Plasma by High-Performance Liquid Chromatography with UV Detection: Application to Therapeutic Drug Monitoring","volume":"55","author":"Verdier","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","first-page":"153","article-title":"Talanta Rapid quantification of six b -lactams to optimize dosage regimens in severely septic patients","volume":"103","author":"Wolff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2018.04.033","article-title":"Validation of an LC-MS\/MS method for simultaneous quantification of venlafaxine and its five metabolites in rat plasma and its application in a pharmacokinetic study","volume":"1087","author":"Gu","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpba.2017.10.023","article-title":"A UHPLC-MS\/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent","volume":"148","author":"Naicker","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_24","first-page":"1246","article-title":"The use of liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of antibiotics in cancer patients","volume":"55","author":"Jantsch","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1179\/1973947814Y.0000000209","article-title":"Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"27","author":"Barco","year":"2015","journal-title":"J. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.talanta.2013.07.043","article-title":"Talanta Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry","volume":"116","author":"Tsai","year":"2013","journal-title":"Talanta"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pawliszyn, J. (2012). Handbook of Solid Phase Microextraction, Chemical Industry Press of China. [1st ed.].","DOI":"10.1016\/B978-0-12-416017-0.00001-2"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.trac.2019.02.029","article-title":"SPME in clinical, pharmaceutical, and biotechnological research-how far are we from daily practice?","volume":"205","author":"Filipiak","year":"2019","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_29","unstructured":"(2020, November 09). US Food and Drug Administration Bioanalytical Method Validation Guidance for Industry, Available online: https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10096-019-03769-8","article-title":"Diagnostic and medical needs for therapeutic drug monitoring of antibiotics","volume":"39","author":"Mabilat","year":"2019","journal-title":"Eur. J. Clin. Microbiol Infect. Dis"},{"key":"ref_31","first-page":"4734","article-title":"Simultaneous Determination of Eight \u03b2-Lactam Antibiotics, Performance Liquid Chromatography with Ultraviolet Detection","volume":"60","author":"Legrand","year":"2016","journal-title":"J. Food Drug Analys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.talanta.2009.06.034","article-title":"Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, cefixime and cefoperazone","volume":"80","author":"Nemutlu","year":"2009","journal-title":"Talanta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/chromsci\/38.7.270","article-title":"Theory of Solid-Phase Microextraction","volume":"38","author":"Pawliszyn","year":"2000","journal-title":"J. Chromatogr. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.4155\/bio.11.210","article-title":"Solid-phase microextraction: A multi-purpose microtechnique","volume":"3","author":"Bojko","year":"2011","journal-title":"Bioanalysis"},{"key":"ref_35","unstructured":"Pfizer Ltd. (2021, September 22). Tazocin 4 g\/0.5 g Powder for Solution for Infusion. Electron. Med. Compend., Available online: http:\/\/www.medicines.org.uk\/emc\/medicine\/28280."},{"key":"ref_36","unstructured":"(2021, September 22). SPC Primaxin IV 500 mg\/500 mg Powder for Solution for Infusion. Available online: https:\/\/www.medicines.org.uk\/emc\/product\/1515."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/3\/926\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:10:45Z","timestamp":1760134245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/3\/926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["molecules27030926"],"URL":"https:\/\/doi.org\/10.3390\/molecules27030926","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]}}}